NEWRON PHARMACEUTICALS S.P.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7 CHF | 0.00% |
|
-3.45% | +41.41% |
| Apr. 17 | Newron Pharmaceuticals Appoints Margarita Chavez as Independent Board Member | CI |
| Mar. 19 | Newron Pharmaceuticals S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Newron Pharmaceuticals S.p.A.
b35bf955044416729eb6d50178.GZ4t1KldodowuF44s77YdsiJD0ddghwOd0OTrk_50u8.Vf99hscu-epS7g5v_-TuPp_vPx8U5FE8MAf5wD-_mJgu6BrlxBHvmQOBDw~37a71122442a051ab0d1114b1ffa7a5f
Upcoming events on Newron Pharmaceuticals S.p.A.
Past events on Newron Pharmaceuticals S.p.A.
| 2024-04-17 04:00 am | Annual General Meeting |
| 2024-04-02 | Schizophrenia International Research Society Congress |
| 2024-03-19 10:00 am | Q4 2023 Earnings Call |
| 2024-03-19 02:00 am | Q4 2023 Earnings Release |
| 2024-01-04 09:00 am | Evenamide Phase 2 Study Results Call |
| 2023-11-26 | German Equity Forum |
| 2023-11-13 | Jefferies London Healthcare Conference |
| 2023-10-06 | ECNP Congress |
| 2023-09-12 | Investora Conference |
| 2023-08-04 01:00 am | Q2 2023 Earnings Release |
| 2023-05-14 | German Spring Conference |
| 2023-05-13 12:30 pm | Schizophrenia International Research Society Congress |
| 2023-05-12 12:00 pm | Schizophrenia International Research Society Congress |
| 2023-05-12 11:00 am | Schizophrenia International Research Society Congress |
| 2023-05-10 | Schizophrenia International Research Society Congress |
| 2023-05-09 10:15 am | CINP of Neuropsychopharmacology World Congress |
| 2023-05-08 05:30 pm | CINP of Neuropsychopharmacology World Congress |
| 2023-05-08 12:15 pm | CINP of Neuropsychopharmacology World Congress |
| 2023-04-17 | Annual General Meeting |
| 2023-03-27 | Psychiatry European Congress |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 7,04 7,00 0.61% | 5,26 5,85 -10.15% | 5,76 5,59 2.99% | 6,09 6,53 -6.72% | 9,06 8,02 12.98% | 36,0 |
|
EBITDA Million EUR | Released Forecast Spread | -20,7 -23,5 11.88% | -17,8 -19,9 10.24% | -12,1 -17,7 31.37% | -13,1 -14,1 7.09% | 0,00 -13,6 - | 18,5 |
|
EBIT Million EUR | Released Forecast Spread | -20,9 -25,1 16.62% | -18,1 -20,0 9.83% | -12,4 -17,9 30.97% | -13,3 -13,9 4.55% | -11,6 -13,0 10.85% | 18,4 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -20,2 -24,9 18.87% | -19,6 -20,9 6.03% | -14,9 -20,2 26.32% | -17,5 -18,1 3.25% | 0,00 -16,1 - | 14,7 |
|
Net income Million EUR | Released Forecast Spread | -20,2 -24,9 18.71% | -21,0 -37,0 43.2% | -14,9 -20,2 26.23% | -17,5 -18,1 3.13% | -16,2 -16,1 -0.74% | 13,7 |
|
EPS EUR | Released Forecast Spread | -1,13 -1,53 26.14% | -1,18 -1,17 -0.85% | -0,84 -1,13 25.66% | -0,98 -1,01 2.97% | -0,91 -0,91 -0.37% | 0,78 |
| Announcement Date | 05/03/20 | 16/03/21 | 15/03/22 | 14/03/23 | 19/03/24 | - |
Quarterly results
| Fiscal Period | December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 |
|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 4,81 6,20 -22.48% | 2,75 3,20 -14.09% | 3,09 3,00 3.03% | ||
|
EBIT Million EUR | Released Forecast Spread | -6,46 -12,2 47.06% | -8,10 -11,5 29.57% | -4,47 -10,0 55.31% | ||
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -6,12 -12,2 49.82% | -9,12 -12,5 27.03% | -5,82 -11,2 48.02% | ||
|
Net income Million EUR | Released Forecast Spread | -6,16 -12,2 49.5% | -10,5 | -10,5 -12,5 16.04% | -9,06 | -5,84 -11,2 47.88% |
|
EPS EUR | Released Forecast Spread | -0,34 -0,68 50% | -0,59 | -0,59 -0,70 15.71% | -0,51 | -0,33 -0,63 47.62% |
| Announcement Date | 05/03/20 | 15/09/20 | 16/03/21 | 16/09/21 | 15/03/22 |
More events
Past sector events for Newron Pharmaceuticals S.p.A.
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NWRN Stock
- Calendar Newron Pharmaceuticals S.p.A.
